TRANSFORMING THERAPEUTICS

What this means for you

This application is over — abandoned 17 Dec 2006. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

78203287

Mark type

Word mark

Filed

14 Jan 2003

Published for opposition

23 Sept 2003

Abandoned

17 Dec 2006

Attorney of record

Bruce W. Schwab, Esq.

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system

Owner

• Nektar Therapeutics, San Carlos, CA, US
• Inhale Therapeutic Systems, Inc., San Carlos, CA, US
• Inhale Therapeutic Systems, Inc., San Carlos, CA, US

Prosecution history

• 28 Feb 2007 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
• 28 Feb 2007 — ABANDONMENT - NO USE STATEMENT FILED
• 28 Jun 2006 — SOU EXTENSION 5 GRANTED
• 30 May 2006 — SOU EXTENSION 5 FILED
• 30 May 2006 — PAPER RECEIVED
• 13 Jan 2006 — SOU EXTENSION 4 GRANTED
• 13 Dec 2005 — SOU EXTENSION 4 FILED
• 13 Dec 2005 — PAPER RECEIVED
• 20 Jun 2005 — SOU EXTENSION 3 GRANTED
• 10 Jun 2005 — SOU EXTENSION 3 FILED
• 10 Jun 2005 — PAPER RECEIVED
• 18 Nov 2004 — SOU EXTENSION 2 GRANTED
• 18 Nov 2004 — SOU EXTENSION 2 FILED
• 18 Nov 2004 — PAPER RECEIVED
• 14 Apr 2004 — DIVISIONAL PROCESSING COMPLETE